AAIC24 (Alzheimer’s Association International Conference)
Event details
Date
Jul 28-Aug 1, 2024
Location
Philadelphia, PA
The Alzheimer’s Association International Conference (AAIC) is the world’s largest meeting dedicated to advancing dementia science. Each year, AAIC convenes researchers, clinicians, and dementia-related professionals from all career stages to share breaking research discoveries that will lead to methods of prevention, treatment and improvements in diagnosis for Alzheimer’s disease. From basic science to dementia care, every aspect of the field’s growing knowledge of dementia is incorporated into this world-class conference. Share theories, breakthroughs and best practices while exploring opportunities to accelerate your work and elevate your career.
Join us
Meet Olink at booth 1237.
Exhibition hours
Sunday, July 28: 9:00 AM – 4:30 PM
Monday, July 29: 9:00 AM – 4:30 PM
Tuesday, July 29: 9:00 AM – 4:30 PM
Wednesday, July 31: 9:00 AM – 4:00 PM
We will be offering hands-on walkthroughs of the workflow for the Olink® Signature Q100 at our booth. We will also demonstrate how to use Olink® Insight to accelerate your proteomics research, see data in new ways, and access exclusive datasets.
Our speakers
This year, we will feature two distinguished speakers at the Product Theatre presentation.
Wednesday July 31, 2024, from 1:20 to 2:00 pm
Center of the Exhibit Hall (Booth No 1017) in the Convention Center
Carlos Cruchaga, PhD
Professor of Psychiatry, Washington University School of Medicine in St. Louis, Director, NeuroGenomics and Informatics Center
Dr. Cruchaga’s Research is focused on genetic and multi-omic approaches to identify novel variants, genes and pathways implicated in neurodegeneration, with the goal of understanding the biology of neurodegenerative diseases.
Dr. Rawan Tarawneh, MD
Associate Professor of Neurology Director, Cognitive Neurology Director, Memory and Aging Clinic University of New Mexico
The Tarawneh Biomarker Discovery Laboratory is dedicated to the identification of novel fluid biomarkers for neurological disorders with a focus on AD (Alzheimer’s Disease) and other neurodegenerative disorders.
